Table 1.
Demographic and clinical characteristics of participants
| Characteristics | Patients (n = 131) | HC (n = 70) | U/χ2 | P value | |
|---|---|---|---|---|---|
| PD (n = 57) | MSA (n = 74) | ||||
| Age (years) | 63.47 ± 7.85a | 65.96 ± 6.51 | 64.97 ± 6.66 | 2.06 | 0.13 |
| Gender (M/F) | 30/27 | 35/39 | 34/36 | 0.387 | 0.82 |
| Disease duration | 2.88 ± 1.56 | 2.27 ± 0.92 | N | 21.474 | < 0.001*** |
| UPDRSIII score | 42.42 ± 6.14 | 43.19 ± 8.59 | N | −0.60 | 0.55 |
| MoCA score | 22.93 ± 2.17b | 22.16 ± 2.20c | 26.99 ± 1.52 | 119.93 | < 0.001*** |
Disease duration Duration from onset of PD symptoms to scan (Years)
***denotes p value less than 0.001
adenotes p value less than 0.05 between PD and MSA
bdenotes p value less than 0.05 between PD and HC
cdenotes p value less than 0.05 between MSA and HC